CONSTANT LEVERAGE LONG - SANOFI Share Price

Certificat

RZ7MB

FRBNPP067HP4

Market Closed - Euronext Paris 15:12:57 21/12/2023 GMT
7.175 EUR -10.92% Intraday chart for CONSTANT LEVERAGE LONG - SANOFI
1 month+33.24%

Static data

Product typeExotic Products
Buy / SellCALL
Underlying SANOFI
IssuerLogo Issuer BNP Paribas BNP Paribas
RZ7MB
ISINFRBNPP067HP4
Date issued 21/11/2023
Maturity Unlimited
Parity 1 : 1
Emission price 5
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 8.475
Lowest since issue 2.682
Spread 0.9
Spread %11.55%

Company Profile

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Sector
-
More about the company

Ratings for Sanofi

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Sanofi

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
91.13 EUR
Average target price
108.2 EUR
Spread / Average Target
+18.72%
Consensus
  1. Stock Market
  2. Certificates
  3. RZ7MB Certificat
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW